Money from the national opioid settlements began flowing to the states in May 2022 and as of December 15, 2022, more than $2.1 billion had been paid to the states, as reported by the national settlement administrator. ![]() The Endo settlement is valued at $450 million. The settlement is subject to states signing onto the agreement in sufficient numbers as determined by Teva. The Teva and Allergan settlement is valued at $6.6 billion with up to $1.2 billion being provided by Teva in the form of generic naloxone. In addition to the pharmacy settlements, major agreements with manufacturers Teva, Allergan, and Endo were announced in 2022. As set forth in the agreements, Walgreens would pay $5.7 billion over 15 years, CVS $5 billion over 10 years, and Walmart $3.1 billion as an expedited payment. As the year ended, states have begun announcing their participation in the settlements. In November, agreements in principle were announced with CVS, Walgreens, and Walmart which were valued at $13.8 billion, dependent upon a sufficient number of states and governmental subdivisions signing off on the settlement. Opioids Settlements Lead to Billions of Dollars in Relief for State and Local Governments to Address Epidemicįollowing the 2021 opioids settlements with McKinsey & Company, Purdue Pharma and the Sackler family, three pharmaceutical distributors and Johnson & Johnson, litigation with pharmacy chains took center stage in 2022. ![]() Attorneys general also carried out important enforcement actions across the consumer protection landscape as well as policy initiatives to protect consumers. Settlements valued at $2.9 billion were obtained through a variety of other multistate actions, the largest being the $1.85 billion settlement with student loan servicer Navient (formerly Sallie Mae), a $438.5 million settlement with e-cigarette company JUUL Labs, and a nearly $400 million settlement with Google over its location tracking practices.īut these are not the only areas where attorneys general were active and achieving important results. Combined with the $26 billion obtained through the 2021 National Opioids Settlement with other manufacturers and distributors, the total monetary value totals nearly $50 billion nationally. As 2023 begins, this Year in Review examines the consumer protection work the nation’s attorneys general undertook in 2022.Īttorneys general took action on numerous fronts last year, obtaining $22.5 billion in opioids-related settlements from manufacturers, pharmacies and retailers.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |